Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 13.
doi: 10.1007/s10557-023-07508-2. Online ahead of print.

Trimetazidine to Reduce Myocardial Fibrosis-Competing Interests with SGLT2 Inhibitors?

Tyler B Moran  1 , Masafumi Kitakaze  2 , Yochai Birnbaum  3
Affiliations
Editorial

Trimetazidine to Reduce Myocardial Fibrosis-Competing Interests with SGLT2 Inhibitors?

Tyler B Moran et al. Cardiovasc Drugs Ther. .
No abstract available

PubMed Disclaimer

References

    1. Qian G, Xin A, Jiang X, et al. Early trimetazidine therapy in patients undergoing primary percutaneous coronary intervention for ST segment elevation myocardial infarction reduces myocardial infarction size. Cardiovasc Drugs Ther. 2023;37(3):497–506. https://doi.org/10.1007/s10557-021-07259-y - DOI - PubMed
    1. Ferrari R, Ford I, Fox K, et al. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics. Am Heart J. 2019;210:98–107. https://doi.org/10.1016/j.ahj.2018.12.015 - DOI - PubMed
    1. Marzilli M, Vinereanu D, Lopaschuk G, et al. Trimetazidine in cardiovascular medicine. Int J Cardiol. 2019;293:39–44. https://doi.org/10.1016/j.ijcard.2019.05.063 - DOI - PubMed
    1. Honka H, Solis-Herrera C, Triplitt C, et al. Therapeutic manipulation of myocardial metabolism: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77(16):2022–39. https://doi.org/10.1016/j.jacc.2021.02.057 - DOI - PubMed
    1. Belhani D, Fanton L, Vaillant F, et al. Cardiac lesions induced by testosterone: protective effects of dexrazoxane and trimetazidine. Cardiovasc Toxicol. 2009;9(2):64–9. https://doi.org/10.1007/s12012-009-9041-7 - DOI - PubMed

Publication types

LinkOut - more resources